Literature DB >> 242321

The purification and properties of peroxidase in Mycobacterium tuberculosis H37Rv and its possible role in the mechanism of action of isonicotinic acid hydrazide.

B G Devi, M S Shaila, T Ramakrishnan, K P Gopinathan.   

Abstract

Peroxidase from Mycobacterium tuberculosis H37Rv was purified to homogeneity. The homogeneous protein exhibits catalase and Y (Youatt's)-enzyme activities in addition to peroxidase activity. Further confirmation that the three activities are due to a single enzyme was accomplished by other criteria, such as differential thermal inactivation, sensitivity to different inhibitors, and co-purification. The Y enzyme (peroxidase) was separated from NADase (NAD+ glycohydrolase) inhibitor by gel filtration on Sephadex G-200. The molecular weights of peroxidase and NADase inhibitor, as determined by gel filtration, are 240000 and 98000 respectively. The Y enzyme shows two Km values for both isoniazid (isonicotinic acid hydrazide) and NAD at low and high concentrations. Analysis of the data by Hill plots revealed that the enzyme has one binding site at lower substrate concentrations and more than one at higher substrate concentration. The enzyme contains 6g-atoms of iron/mol. Highly purified preparations of peroxidases from different sources catalyse the Y-enzyme reaction, suggesting that the nature of the reaction may be a peroxidatic oxidation of isoniazid. Moreover, the Y-enzyme reaction is enhanced by O2. Isoniazid-resistant mutants do not exhibit Y-enzyme, peroxidase or catalase activities, and do not take up isoniazid. The Y-enzyme reaction is therefore implicated in the uptake of the drug.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 242321      PMCID: PMC1165605          DOI: 10.1042/bj1490187

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  [Attempts at differentiation of mycobacteria sensitive and resistant to INH by the aid of quantitative and qualitative tests of peroxidase activity. Discussion of technical problems].

Authors:  A ANDREJEW; C GERNEZ-RIEUX; A TACQUET
Journal:  Ann Inst Pasteur (Paris)       Date:  1960-12

2.  Catalase and peroxidase in mycobacteria. Possible relationship to the mode of action of isoniazid.

Authors:  F WINDER
Journal:  Am Rev Respir Dis       Date:  1960-01

3.  [The effect of isoniazid and D-cycloserine on purified peroxidase and on the peroxidase activity of Mycobacterium tuberculosis].

Authors:  A ANDREJEW; C GERNEZ-RIEUX; A TACQUET
Journal:  Ann Inst Pasteur (Paris)       Date:  1959-02

4.  Further mutational studies on the isoniazid resistance of Mycobacterium tuberculosis.

Authors:  M TSUKAMURA
Journal:  Jpn J Microbiol       Date:  1960-04

5.  Relation of pyrogallol-peroxidative activity to isoniazid resistance in Mycobacterium tuberculosis.

Authors:  L W HEDGECOCK; I O FAUCHER
Journal:  Am Rev Tuberc       Date:  1957-04

6.  Localization of mycobacterial enzymes.

Authors:  R W DARTER; I MILLMAN
Journal:  Proc Soc Exp Biol Med       Date:  1957-07

7.  [Not Available].

Authors:  A ANDREJEW; C GERNEZRIEUX; A TACQUET
Journal:  Ann Inst Pasteur (Paris)       Date:  1956-11

8.  Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients.

Authors:  G MIDDLEBROOK; M L COHN; W B SCHAEFER
Journal:  Am Rev Tuberc       Date:  1954-11

9.  Studies on isoniazid and tubercle bacilli. I. The isolation of isoniazid-resistant mutants in vitro.

Authors:  M L COHN; U ODA; C KOVITZ; G MIDDLEBROOK
Journal:  Am Rev Tuberc       Date:  1954-09

10.  Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.

Authors:  G MIDDLEBROOK
Journal:  Am Rev Tuberc       Date:  1954-03
View more
  11 in total

1.  Enzymatic and nonenzymatic superoxide-generating reactions of isoniazid.

Authors:  H A Shoeb; B U Bowman; A C Ottolenghi; A J Merola
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

2.  Differentiation of catalases in Mycobacterium phlei on the basis of susceptibility to isoniazid: association with peroxidase and acquired resistance to isoniazid.

Authors:  W B Davis; D M Phillips
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

3.  Evidence for the generation of active oxygen by isoniazid treatment of extracts of Mycobacterium tuberculosis H37Ra.

Authors:  H A Shoeb; B U Bowman; A C Ottolenghi; A J Merola
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

4.  First structural evidence for the mode of diffusion of aromatic ligands and ligand-induced closure of the hydrophobic channel in heme peroxidases.

Authors:  Amit K Singh; Nagendra Singh; Ashutosh Tiwari; Mau Sinha; Gajraj S Kushwaha; Punit Kaur; A Srinivasan; Sujata Sharma; T P Singh
Journal:  J Biol Inorg Chem       Date:  2010-05-12       Impact factor: 3.358

5.  Mode of binding of the tuberculosis prodrug isoniazid to heme peroxidases: binding studies and crystal structure of bovine lactoperoxidase with isoniazid at 2.7 A resolution.

Authors:  Amit K Singh; Ramasamy P Kumar; Nisha Pandey; Nagendra Singh; Mau Sinha; Asha Bhushan; Punit Kaur; Sujata Sharma; Tej P Singh
Journal:  J Biol Chem       Date:  2009-11-11       Impact factor: 5.157

6.  Catalases, peroxidases, and superoxide dismutases in Mycobacterium leprae and other mycobacteria studied by crossed immunoelectrophoresis and polyacrylamide gel electrophoresis.

Authors:  S T Lygren; O Closs; H Bercouvier; L G Wayne
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

7.  Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum.

Authors:  A Quémard; C Lacave; G Lanéelle
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

8.  Identification of a nicotinamide adenine dinucleotide glycohydrolase and an associated inhibitor in isoniazid-susceptible and -resistant Mycobacterium phlei.

Authors:  W B Davis
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

9.  Peroxidase-mediated oxidation of isoniazid.

Authors:  H A Shoeb; B U Bowman; A C Ottolenghi; A J Merola
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

10.  Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans.

Authors:  Alexander S Pym; Brigitte Saint-Joanis; Stewart T Cole
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.